Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICARDIS proof-of-concept study of insulin sensitivity in overweight or obese non-diabetic normotensive adults
2004-003986-34Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity and Overweight comparing MICARDIS with Placebo (2 arms). Primary endpoint: Change in insulin sensitivity index. Started Jan 2005; status: completed.
02
Drugs
telmisartan
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on 2004-003986-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003986-34.